1. Targeting T-cells to Acute Myeloid Leukemia with a Novel Bispecific Antibody Format Burke, Alan Austin 2022 Theses PharmacologyAcute myeloid leukemiaAcute leukemia--TreatmentT cells--Therapeutic usePharmacokineticsCell-mediated cytotoxicity
2. Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial Mayer, Kenneth H.; Seaton, Kelly E.; Grunenberg, Nicole; Isaacs, Abby; Allen, Mary; Ledgerwood, Julie E.; Frank, Ian; Sobieszczyk, Magdalena; Baden, Lindsey R.; Rodriguez, Benigno; Tieu, Hong Van N.; Tomaras, Georgia D.; Deal, Aaron; Goodman, Derrick; Bailer, Robert T.; Ferrari, Guido; Jensen, Ryan; Hural, John; Graham, Barney S.; Mascola, John R.; Corey, Lawrence; Montefiori, David; HVTN 104 Protocol Team; NIAID HIV Vaccine Trials Network 2017 Articles HIV infections—PreventionMonoclonal antibodies--Therapeutic usePharmacokineticsImmunologyVaccines--Design
3. A novel, rapid method to compare the therapeutic windows of oral anticoagulants using the Hill coefficient Chang, Jeremy B.; Quinnies, Kayla M.; Realubit, Ronald B.; Karan Jr., Charles; Rand, Jacob H.; Tatonetti, Nicholas P. 2016 Articles Anticoagulants (Medicine)Oral medicinePharmacokineticsMedicinePharmacology
4. Sequential Designs for Individualized Dosing in Phase I Cancer Clinical Trials Mao, Xuezhou 2014 Theses Drugs--Dose-response relationshipCancer--Treatment--ResearchPharmacokineticsBiometry
5. Unsupervised Deconvolution of Dynamic Imaging Reveals Intratumor Vascular Heterogeneity and Repopulation Dynamics Chen, Li; Choyke, Peter L.; Wang, Niya; Clarke, Robert; Bhujwalla, Zaver M.; Hillman, Elizabeth M.C.; Wang, Ge; Wang, Yue 2014 Articles PharmacokineticsBreast--Cancer--TreatmentTumorsMedical sciencesOncologyBiomedical engineering